Press release
Neuroprotection Market to Reach US$ 60.1 Billion by 2031, Driven by Rising Prevalence of Neurological Disorders and Advancements in Drug Development
Neuroprotection Market
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40553
Market Dynamics
Drivers:
Rising Prevalence of Neurodegenerative Diseases: Increasing cases of Alzheimer's, Parkinson's, and multiple sclerosis are driving demand for neuroprotective drugs.
Advancements in Drug Development: New research in regenerative medicine, stem cell therapy, and novel drug formulations are enhancing neuroprotection treatment outcomes.
Government and Private Funding for Neurological Research: Increased investments in neuroscience and neuroprotection therapies are accelerating innovation.
Aging Population: The growing elderly population, more susceptible to neurodegenerative diseases, is fueling market expansion.
Restraints:
High Costs of Neuroprotective Drugs: Expensive drug development and treatment costs may limit accessibility, especially in developing regions.
Stringent Regulatory Approvals: Complex approval processes for new drugs can delay market entry.
Limited Awareness in Low-income Countries: Lack of awareness and access to neuroprotection therapies in certain regions may hinder market growth.
Opportunities:
Emerging Biomarker-Based Therapies: Increased research in biomarkers for early detection and treatment of neurological disorders presents new opportunities.
Growth in Personalized Medicine: Advancements in genetics and precision medicine are paving the way for individualized neuroprotection therapies.
Increased Collaboration Between Biotech and Pharma Companies: Strategic partnerships are accelerating drug discovery and commercialization.
Competitive Landscape The neuroprotection market is highly competitive, with key players focusing on new drug approvals, mergers, acquisitions, and technological innovations.
Leading companies include:
Daiichi Sankyo Company
Eli Lilly and Company
AbbVie Inc.
Dr. Reddy's Laboratories Ltd.
Teva Pharmaceutical Industries Ltd.
Novartis AG
AstraZeneca plc.
Astrocyte Pharmaceuticals, Inc.
F. Hoffmann-La Roche AG
Biogen Inc.
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40553
Market Segmentation
By Drug Class:
NMDA Receptor Antagonists
Free Radical Trappers
Anti-inflammatory Agents
Mitochondrial Dysfunction Regulators
Others
By Indication:
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Stroke
Others
By End-User:
Hospitals
Specialty Clinics
Research Institutes
Regional Outlook
North America: The largest market due to advanced healthcare infrastructure, strong R&D investments, and high prevalence of neurodegenerative disorders.
Europe: Government-backed neurological research programs and increasing elderly population contribute to market growth.
Asia-Pacific: Expected to witness the highest growth due to increasing healthcare investments, rising disease awareness, and expanding pharmaceutical industry.
Latin America & Middle East & Africa: Steady growth driven by improving healthcare facilities and increasing government support for neurological research.
Explore Latest Research Reports by Transparency Market Research:
Dental Gypsum Market- https://www.globenewswire.com/news-release/2024/03/14/2846441/32656/en/Dental-Gypsum-Market-Projected-to-Reach-USD-180-1-million-by-2031-Growing-at-a-CAGR-of-5-1-Transparency-Market-Research-Inc.html
Aerospace Composites Market- https://www.globenewswire.com/news-release/2024/02/27/2835814/32656/en/Aerospace-Composites-Market-Size-is-Anticipated-to-Reach-USD-40-5-billion-Rising-at-a-CAGR-of-9-7-by-2031-Transparency-Market-Research-Inc.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroprotection Market to Reach US$ 60.1 Billion by 2031, Driven by Rising Prevalence of Neurological Disorders and Advancements in Drug Development here
News-ID: 3908147 • Views: …
More Releases from Transparency Market Research
Functional Coffee Market Expanding at 7.6% CAGR Through 2035 - By Product Type / …
The global functional coffee market was valued at US$ 21.5 Bn in 2024 and is projected to reach US$ 48.1 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2035. This steady growth trajectory reflects the strong convergence of coffee consumption habits with rising demand for functional and wellness-oriented beverages. Functional coffee has transitioned from a niche category to a mainstream product offering,…
Global Electric Face Cleanser Market Poised for Robust Growth, projected to Reac …
The global electric face cleanser market is witnessing a transformative growth phase as consumers increasingly integrate advanced skincare technologies into their daily routines. Valued at USD 9.8 billion in 2025, the market is projected to expand significantly and reach USD 23.6 billion by 2036, growing at a healthy compound annual growth rate (CAGR) of 8.6% from 2026 to 2036. This growth trajectory underscores the rising importance of personal care technology,…
Asthma and COPD Drugs Market to Reach US$ 82.2 Billion by 2036, Growing at 5.7% …
The global asthma and COPD drugs market demonstrated strong fundamentals in 2025, with a valuation of US$ 44.7 Bn, reflecting the essential and recurring nature of respiratory therapeutics. Supported by a growing patient base and continuous pharmaceutical innovation, the market is projected to reach US$ 82.2 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2036.
This growth trajectory highlights the increasing reliance on…
Low-Alcohol Beverages Market Outlook 2035: Global Industry Set to Expand from US …
The global low-alcohol beverages market is undergoing a structural transformation as consumers increasingly prioritize health, moderation, and mindful drinking without sacrificing taste or social experiences. Valued at US$ 2.1 billion in 2024, the market is projected to reach US$ 4.6 billion by 2035, expanding at a healthy CAGR of 7.5% from 2025 to 2035. This sustained growth reflects changing lifestyle preferences, generational shifts in alcohol consumption, and continuous innovation by…
More Releases for Neuroprotection
Breakthrough in Neuroprotection: Nooglutil Shows Promise in Preclinical Studies
A novel neuroprotective agent, Nooglutil [https://www.biofingredients.com/biof-supply-nooglutil-cas-112193-35-8-n-5-hydroxy-3-pyridinylcarbonyl-l-glutamic-acid-product/], has emerged as a promising candidate for treating neurodegenerative disorders, according to recent preclinical research. Developed to address unmet medical needs in Alzheimer's disease (AD), Parkinson's disease (PD), and stroke recovery, Nooglutil combines two active components-nopracitabine and gyltio clone-to enhance neuronal resilience and cognitive function through dual mechanisms.
Mechanism and Preclinical Efficacy
Nopracitabine, a natural neurotransmitter precursor, promotes acetylcholine synthesis, critical for memory and learning .…
Neuroprotection: A Guide to Understanding the Process
Neuroprotection is involvement capable to affect the etiology or the pathogenesis of the neurodegenerative diseases. They delay the onset or the development of neurodegenerative diseases. Neuroprotective products are medications that protect the brain neurons from deterioration and injury.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPMD00002291/?utm_source=OpenPR&utm_medium=10129
These products are used in the cure of several central nervous system complications such as Alzheimer's disease, Parkinson's disease and traumatic brain injuries…
Empowering Neuroprotection: Market Growth Projections & Trends 2024-2031
Report Overview
Neuroprotection Market is expected to grow at a CAGR of 8.2% during the forecast period 2024-2031
Neuroprotection refers to the capacity to promote recovery, salvage, and regeneration of the nervous system's structure, cells, and functions. It involves the prevention of neuronal cell death by inhibiting pathogenic cascades that lead to cellular dysfunction.
Various neurochemical modulators can cause damage to the nervous system, highlighting the importance of therapeutic…
Neuroprotective Agents Market - Empowering Neuroprotection for Optimal Brain Fun …
Newark, New Castle, USA: The "Neuroprotective Agents Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Neuroprotective Agents Market: https://www.growthplusreports.com/report/neuroprotective-agents-market/8412
This latest report researches the industry structure, sales, revenue,…
Neuroprotection Market Share, Sales Channels and Overview Till 2028
Neuroprotection is involvement capable to affect the etiology or the pathogenesis of the neurodegenerative diseases. They delay the onset or the development of neurodegenerative diseases. Neuroprotective products are medications that protect the brain neurons from deterioration and injury. These products are used in the cure of several central nervous system complications such as Alzheimer's disease, Parkinson's disease and traumatic brain injuries among others. Neuroprotective agents in clinical pipelines comprise small-molecule…
Global Neuroprotection Market Research
The Global Neuroprotection Market Research Global Neuroprotection Market Research neuroprotection showcase was esteemed at roughly US$ 47,000.0 Mn in 2016 is anticipated to enroll a development rate of 8.2% from 2017 to 2025, as per another report distributed by Transparency Market Research (TMR) titled "Neuroprotection Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017– 2025". The Global Neuroprotection Market Research report proposes that expanding occurrence and predominance…
